Clinical Trial

Efficacy of CL22205 on Bone Mineral Density and Menopausal Symptoms

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 27, 2025 (before its estimated May 10, 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to evaluate the effect of CL22205 on bone mineral density and menopausal symptoms in women.
Trial Details
NCT Number NCT06899243
Lead Sponsor Eetho Brands, Inc
Conditions Menopausal Symptoms
Enrollment 80 participants
Start Date 2025-03-25
Primary Completion 2026-05-10 (estimated)
Study Completion 2026-08-30 (estimated)
Updated on ClinicalTrials.gov 2025-03-27